Showing results (321-330 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|May 12, 2009
Thiazolidinediones and the influence of media adverse reporting on prescribing attitudes in practice (TZD-IMPACT) studyJacob George, Stuart Hannah, Chim C LangCardiovascular Therapeutics|May 12, 2009
Periplogenin-3-O- -D-glucopyranosyl -(1-->6)- -D-glucopyaranosyl- -(1-->4) -D-cymaropyranoside, isolated from Aegle marmelos protects doxorubicin induced cardiovascular problems and hepatotoxicity in ratsSunanda Panda, Anand KarCardiovascular Therapeutics|November 28, 2008
Allopurinol treatment reduces arterial wave reflection in stroke survivorsFaisel Khan, Jacob George, Kenneth Wong, et al.Cardiovascular Therapeutics|November 28, 2008
Nonequivalence of inhaled and nebulized salbutamol in the assessment of endothelial dysfunctionRoy L Soiza, M Yaqoob Bhat, Mike A Crilly, et al.Cardiovascular Therapeutics|November 28, 2008
Role of adenosine antagonism in the cardiorenal syndromeMustafa M Dohadwala, Michael M GivertzCardiovascular Therapeutics|June 27, 2009
Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic riskP Riley, M Al Bakir, J O'Donohue, et al.Cardiovascular Therapeutics|February 12, 2009
Cardiac functional reserve is diminished in growth hormone-deficient adultsRobert Moisey, Steve Orme, Diane Barker, et al.Cardiovascular Therapeutics|October 15, 2013
Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillationSteven DeitelzweigCardiovascular Therapeutics|April 8, 2010
Natural antioxidants and hypertension: promise and challengesTinoy J Kizhakekuttu, Michael E WidlanskyCardiovascular Therapeutics|April 8, 2010
STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin DDerun Taner Ertugrul, Bunyamin Yavuz, Hicran Cil, et al.Pageof 99